CTRI/2021/10/037636已完成未知
Ceftazidime-Avibactum versus Meropenem with or without Colistin as empiric, first-line treatment of high-risk febrile neutropenia- a randomized, controlled trial. - NA
I0 个研究点目标入组 99 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 99
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •age above 18 years
- •Undergoing treatment for hematological malignancies or bone marrow failure syndromes or stem cell transplantation
- •high-risk febrile neutropenia as defined by
- •Neutropenia-ANC <500/mm3 and expected to fall below 500/mm3 in 48hrs and lasting for >7 days
- •Fever -single oral temperature of 38.3 ? C (101° F) on one occasion or 38 ? C (100.4 ° F) on at least 2 occasions (1 hour apart)
- •and/or significant comorbidities
- •or haemodynamically unstable patients
- •More than 5 days admission in any healthcare facility
排除标准
- •Age <18 years
- •Pregnant or lactating women
- •Patients being treated with palliative intent
研究者
相似试验
已完成
3 期
A clinical trial to study the two antibiotic regimen cefepime and cefeperazone/Sulbactum plus Amikacin in cancer patients with feverCTRI/2017/06/008829Jipmer334
已完成
不适用
Effect of cefepime (CFPM) or meropenem (MEPM) for febrile neutropenia patients with lung cancer. Randomized phase II study.JPRN-UMIN000005275OGIK(Lung oncology group in Kyushu)46
已完成
3 期
A Study Comparing Ceftazidime-Avibactam Versus Meropenem in Hospitalized Adults With Nosocomial PneumoniaNosocomial Pneumonia (NP)Ventilator-associated Pneumonia (VAP)NCT01808092Pfizer969
已完成
不适用
A Multicenter Comparative Study of Cefepime Versus Broad-Spectrum Antibacterial Therapy in Moderate and Severe Bacterial InfectionsPER-032-99BRISTOL MYERS SQUIBB PERÚ S.A.,
尚未招募
Unknown
Study to evaluate clinical effects of Polymyxins and Ceftazidime-Avibactum in critical patients and evaluate which group has better outcomes (CoP CAcRE)CTRI/2023/10/058761Research institution